Cargando…
Human adult pluripotency: Facts and questions
Cellular reprogramming and induced pluripotent stem cell (IPSC) technology demonstrated the plasticity of adult cell fate, opening a new era of cellular modelling and introducing a versatile therapeutic tool for regenerative medicine. While IPSCs are already involved in clinical trials for various r...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354101/ https://www.ncbi.nlm.nih.gov/pubmed/30705711 http://dx.doi.org/10.4252/wjsc.v11.i1.1 |
_version_ | 1783391114415308800 |
---|---|
author | Labusca, Luminita Mashayekhi, Kaveh |
author_facet | Labusca, Luminita Mashayekhi, Kaveh |
author_sort | Labusca, Luminita |
collection | PubMed |
description | Cellular reprogramming and induced pluripotent stem cell (IPSC) technology demonstrated the plasticity of adult cell fate, opening a new era of cellular modelling and introducing a versatile therapeutic tool for regenerative medicine. While IPSCs are already involved in clinical trials for various regenerative purposes, critical questions concerning their medium- and long-term genetic and epigenetic stability still need to be answered. Pluripotent stem cells have been described in the last decades in various mammalian and human tissues (such as bone marrow, blood and adipose tissue). We briefly describe the characteristics of human-derived adult stem cells displaying in vitro and/or in vivo pluripotency while highlighting that the common denominators of their isolation or occurrence within tissue are represented by extreme cellular stress. Spontaneous cellular reprogramming as a survival mechanism favoured by senescence and cellular scarcity could represent an adaptative mechanism. Reprogrammed cells could initiate tissue regeneration or tumour formation dependent on the microenvironment characteristics. Systems biology approaches and lineage tracing within living tissues can be used to clarify the origin of adult pluripotent stem cells and their significance for regeneration and disease. |
format | Online Article Text |
id | pubmed-6354101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-63541012019-01-31 Human adult pluripotency: Facts and questions Labusca, Luminita Mashayekhi, Kaveh World J Stem Cells Editorial Cellular reprogramming and induced pluripotent stem cell (IPSC) technology demonstrated the plasticity of adult cell fate, opening a new era of cellular modelling and introducing a versatile therapeutic tool for regenerative medicine. While IPSCs are already involved in clinical trials for various regenerative purposes, critical questions concerning their medium- and long-term genetic and epigenetic stability still need to be answered. Pluripotent stem cells have been described in the last decades in various mammalian and human tissues (such as bone marrow, blood and adipose tissue). We briefly describe the characteristics of human-derived adult stem cells displaying in vitro and/or in vivo pluripotency while highlighting that the common denominators of their isolation or occurrence within tissue are represented by extreme cellular stress. Spontaneous cellular reprogramming as a survival mechanism favoured by senescence and cellular scarcity could represent an adaptative mechanism. Reprogrammed cells could initiate tissue regeneration or tumour formation dependent on the microenvironment characteristics. Systems biology approaches and lineage tracing within living tissues can be used to clarify the origin of adult pluripotent stem cells and their significance for regeneration and disease. Baishideng Publishing Group Inc 2019-01-26 2019-01-26 /pmc/articles/PMC6354101/ /pubmed/30705711 http://dx.doi.org/10.4252/wjsc.v11.i1.1 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Editorial Labusca, Luminita Mashayekhi, Kaveh Human adult pluripotency: Facts and questions |
title | Human adult pluripotency: Facts and questions |
title_full | Human adult pluripotency: Facts and questions |
title_fullStr | Human adult pluripotency: Facts and questions |
title_full_unstemmed | Human adult pluripotency: Facts and questions |
title_short | Human adult pluripotency: Facts and questions |
title_sort | human adult pluripotency: facts and questions |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354101/ https://www.ncbi.nlm.nih.gov/pubmed/30705711 http://dx.doi.org/10.4252/wjsc.v11.i1.1 |
work_keys_str_mv | AT labuscaluminita humanadultpluripotencyfactsandquestions AT mashayekhikaveh humanadultpluripotencyfactsandquestions |